The American people deserve a response to the NECC outbreak so that we can ensure that this never happens again.
One main reason for the NECC outbreak was much confusion regarding FDA's authorities and the proper role of the States.
It is clear to me that Food and Drug needs strong and clear authority over compounding pharmacies, which it now lacks.
I have long believed that we must provide agencies like FDA with the necessary authorities and researchers and resources to properly protect...
I am committed, like most of my colleagues here, to seeing to it that we work towards a proper bipartisan solution to the problem.
The practical effect of such judicial review would be to slow or to hinder the Commission's ability to promulgate new rules.
Is it probable that interested stakeholders will challenge the Commission's application of such terms in the event stakeholders disagree?
The practical effect of such challenges would be to hinder and to slow the Commission's ability to agree on new rules.
This requirement will invite strict scrutiny by the courts of merger conditions imposed by the Commission.
The draft bill then could conceivably hinder the Commission rulemakings but also severely restrict its ability to approve mergers.
One of the draft bill's primary effects would be to sand the gears of the Commission when it comes to rulemaking.